Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001205107 | SCV001376344 | uncertain significance | Severe combined immunodeficiency due to DNA-PKcs deficiency | 2022-08-23 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 375 of the PRKDC protein (p.Val375Leu). This variant is present in population databases (rs763664375, gnomAD 0.002%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 936328). This variant has not been reported in the literature in individuals affected with PRKDC-related conditions. |
Ambry Genetics | RCV004033638 | SCV003944293 | uncertain significance | not specified | 2023-06-01 | criteria provided, single submitter | clinical testing | The c.1123G>C (p.V375L) alteration is located in exon 12 (coding exon 12) of the PRKDC gene. This alteration results from a G to C substitution at nucleotide position 1123, causing the valine (V) at amino acid position 375 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |